Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.21% |
| 2 | Healthcare | 10.45% |
| 3 | Technology | 8.65% |
| 4 | Financials | 8.6% |
| 5 | Consumer Discretionary | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
PUT
Illumina
ILMN
$33.5B
| $6M | 0.01% |
18,607
-86,455
| -82% | -$26.2M |
|
|
CTACU
1752
DELISTED
ChaSerg Technology Acquisition Corp. Unit
CTACU
| $6M | 0.01% |
500,000
| – | – |
|
1753
British American Tobacco
BTI
$121B
| $5.99M | 0.01% |
141,059
+120,784
| +596% | +$4.55M |
|
1754
PUT
Zimmer Biomet
ZBH
$19B
| $5.99M | 0.01% |
41,200
-25,750
| -38% | -$3.55M |
|
1755
Ultrapar
UGP
$6.87B
| $5.99M | 0.01% |
956,031
-228,971
| -19% | -$1.16M |
|
|
AMAG
1756
DELISTED
AMAG Pharmaceuticals
AMAG
| $5.98M | 0.01% |
491,713
-310,894
| -39% | -$3.4M |
|
1757
Marvell Technology
MRVL
$199B
| $5.98M | 0.01% |
225,261
-1,348,053
| -86% | -$34.2M |
|
1758
Tilly's
TLYS
$120M
| $5.98M | 0.01% |
488,240
-252,839
| -34% | -$2.67M |
|
1759
TriCo Bancshares
TCBK
$1.73B
| $5.97M | 0.01% |
146,415
-66,122
| -31% | -$2.52M |
|
1760
Mercado Libre
MELI
$98.9B
| $5.97M | 0.01% |
10,446
+7,300
| +232% | +$4.04M |
|
1761
Protagonist Therapeutics
PTGX
$9.5B
| $5.97M | 0.01% |
846,994
+9,102
| +1% | +$90.4K |
|
1762
PUT
Zoetis
ZTS
$31.5B
| $5.97M | 0.01% |
+45,100
| New | +$5.6M |
|
1763
Zoom
ZM
$28.8B
| $5.97M | 0.01% |
87,684
+79,011
| +911% | +$5.44M |
|
1764
Valley National Bancorp
VLY
$7.73B
| $5.96M | 0.01% |
520,264
+439,611
| +545% | +$5.06M |
|
1765
Silgan Holdings
SLGN
$4.46B
| $5.95M | 0.01% |
191,527
-130,169
| -40% | -$3.98M |
|
1766
Oaktree Specialty Lending
OCSL
$1.15B
| $5.95M | 0.01% |
363,340
+19,517
| +6% | +$307K |
|
|
NGHC
1767
DELISTED
National General Holdings Corp
NGHC
| $5.94M | 0.01% |
268,844
+36,619
| +16% | +$801K |
|
1768
Encore Capital Group
ECPG
$2.19B
| $5.94M | 0.01% |
167,918
+44,166
| +36% | +$1.54M |
|
1769
GoPro
GPRO
$110M
| $5.92M | 0.01% |
1,364,149
+1,143,894
| +519% | +$4.75M |
|
1770
Franklin Electric
FELE
$4.49B
| $5.92M | 0.01% |
103,197
+90,718
| +727% | +$4.79M |
|
1771
i3 Verticals
IIIV
$295M
| $5.91M | 0.01% |
+209,264
| New | +$4.94M |
|
|
BMCH
1772
DELISTED
BMC Stock Holdings, Inc
BMCH
| $5.9M | 0.01% |
+205,599
| New | +$5.78M |
|
|
ALX
1773
Alexander's
ALX
$1.4B
| $5.88M | 0.01% |
17,789
+373
| +2% | +$124K |
|
|
CBAY
1774
DELISTED
Cymabay Therapeutics
CBAY
| $5.87M | 0.01% |
2,993,645
-730,152
| -20% | -$2.74M |
|
1775
Digital Turbine
APPS
$1.36B
| $5.87M | 0.01% |
822,781
+461,932
| +128% | +$3.44M |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $4.28B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.